All In Biotech

Free tool

FAERS Monitor: Entresto Sprinkle

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 218591 or its brand name (Entresto Sprinkle, Sacubitril, Valsartan). Reports on generic versions are filed under their own applications.

Reports

116,184

Serious

59,720

51% of reports

Hospitalization

21,241

Death reported

14,200

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hypotension11,679
  • death9,164
  • dyspnoea9,055
  • dizziness8,785
  • fatigue8,758
  • cough7,892
  • wrong technique in product usage process7,341
  • weight decreased5,230
  • cardiac failure4,550
  • malaise4,473
  • asthenia3,844
  • weight increased3,520
  • blood pressure decreased3,216
  • product dose omission issue2,873
  • myocardial infarction2,793

Reports by year received

View as table
YearReports
20132
20142
2015971
20166,442
20177,878
201812,218
201912,941
202012,382
202116,985
202219,265
202316,689
20244,599
20253,594
20262,216

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,937,975 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypotensionSignal11,67911.110.9102,374
cardiac failureSignal4,55010.810.538,376
blood pressure decreasedSignal3,2169.28.822,297
wrong technique in product usage processSignal7,3416.86.635,106
coughSignal7,8925.25.126,464
weight decreasedSignal5,2303.43.38,986
dizzinessSignal8,7853.23.213,590
myocardial infarctionSignal2,7932.92.83,519
dyspnoeaSignal9,0552.92.911,611
weight increasedSignal3,5202.92.84,280
fatigueSignal8,7582.02.04,823
death9,1641.91.94,274
asthenia3,8441.91.81,538
malaise4,4731.91.81,781
product dose omission issue2,8731.81.7978

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.